Ubs Group Ag Kodiak Sciences Inc. Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

A detailed history of Ubs Group Ag transactions in Kodiak Sciences Inc. stock. As of the latest transaction made, Ubs Group Ag holds 15,731 shares of KOD stock, worth $91,082. This represents 0.0% of its overall portfolio holdings.

Number of Shares

15,731

Previous 13,709 14.75%

Holding current value

$91,082

Previous $32,000 28.13%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$2.2 - $3.25 $4,448 - $6,571	2,022 Added 14.75%	15,731 $41,000
Q2 2024 Aug 13, 2024	SELL	$2.29 - $4.48 $57,227 - $111,955	-24,990 Reduced 64.58%	13,709 $32,000
Q1 2024 May 13, 2024	SELL	$3.01 - $7.45 $13,313 - $32,951	-4,423 Reduced 10.26%	38,699 $203,000
Q4 2023 Feb 09, 2024	BUY	$1.4 - $3.24 $27,626 - $63,934	19,733 Added 84.37%	43,122 $131,000
Q3 2023 Nov 09, 2023	BUY	$1.8 - $7.49 $3,688 - $15,347	2,049 Added 9.6%	23,389 $42,000
Q2 2023 Aug 11, 2023	BUY	$4.3 - $9.48 $38,072 - $83,935	8,854 Added 70.91%	21,340 $147,000
Q1 2023 May 12, 2023	BUY	$4.81 - $8.88 $500 - $923	104 Added 0.84%	12,486 $77,000
Q4 2022 Feb 08, 2023	BUY	$6.52 - $8.05 $37,861 - $46,746	5,807 Added 88.32%	12,382 $88,000
Q3 2022 Nov 10, 2022	BUY	$7.57 - $12.5 $49,583 - $81,875	6,550 Added 26200.0%	6,575 $51,000
Q1 2022 May 16, 2022	SELL	$7.09 - $89.45 $14,527 - $183,283	-2,049 Reduced 98.79%	25 $0
Q4 2021 Feb 14, 2022	SELL	$80.85 - $128.49 $2.01 Million - $3.19 Million	-24,823 Reduced 92.29%	2,074 $176,000
Q3 2021 Nov 15, 2021	BUY	$81.97 - $106.94 $2.19 Million - $2.86 Million	26,766 Added 20432.06%	26,897 $2.58 Million
Q2 2021 Aug 13, 2021	SELL	$77.2 - $126.54 $1.48 Million - $2.43 Million	-19,219 Reduced 99.32%	131 $12,000
Q1 2021 May 12, 2021	BUY	$110.45 - $164.47 $1.14 Million - $1.69 Million	10,291 Added 113.6%	19,350 $2.2 Million
Q4 2020 Feb 11, 2021	BUY	$60.78 - $154.03 $507,816 - $1.29 Million	8,355 Added 1186.79%	9,059 $1.33 Million
Q3 2020 Nov 12, 2020	BUY	$45.05 - $59.27 $24,056 - $31,650	534 Added 314.12%	704 $42,000
Q2 2020 Jul 31, 2020	SELL	$42.74 - $66.25 $357,648 - $554,380	-8,368 Reduced 98.01%	170 $9,000
Q1 2020 May 01, 2020	SELL	$38.18 - $73.95 $434,182 - $840,959	-11,372 Reduced 57.12%	8,538 $407,000
Q4 2019 Feb 14, 2020	SELL	$13.9 - $76.65 $20,391 - $112,445	-1,467 Reduced 6.86%	19,910 $1.43 Million
Q3 2019 Nov 14, 2019	BUY	$10.24 - $17.57 $156,631 - $268,750	15,296 Added 251.54%	21,377 $307,000
Q2 2019 Aug 14, 2019	BUY	$6.2 - $12.0 $37,702 - $72,972	6,081 New	6,081 $71,000
Q1 2019 May 14, 2019	SELL	$6.43 - $9.44 $22,543 - $33,096	-3,506 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$6.11 - $10.43 $21,421 - $36,567	3,506 New	3,506 $25,000

Others Institutions Holding KOD

# of Institutions

Shares Held

39M

Call Options Held

6.5K

Put Options Held

5.8K

View Full List

About Kodiak Sciences Inc.

Ticker KOD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,040,200
Market Cap $301M
Description
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...

More about KOD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account